Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 4 Study of Medical Therapy Versus Medical Therapy Plus Renal Artery Stenting in Preventing the Progression of Renal Failure in Atherosclerotic Renovascular Disease

NCT01023373 is registered in ClinicalTrials.gov with Azienda Unita Sanitaria Locale di Piacenza as lead sponsor.

NCT NCT01023373
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01023373 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 4 Study of Medical Therapy Versus Medical Therapy Plus Renal Artery Stenting in Preventing the Progression of Renal Failure in Atherosclerotic Renovascular Disease
Lead sponsor
Azienda Unita Sanitaria Locale di Piacenza
Phase
Phase 4
Overall status
Unknown status
Start date
October 31, 2003
Completion date
May 31, 2009
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, chronic kidney disease, hypertension, renovascular, ischemic nephropathy, renal artery stenosis